PARKINSON DISEASE, IDIOPATHIC
Clinical trials for PARKINSON DISEASE, IDIOPATHIC explained in plain language.
Never miss a new study
Get alerted when new PARKINSON DISEASE, IDIOPATHIC trials appear
Sign up with your email to follow new studies for PARKINSON DISEASE, IDIOPATHIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to slow Parkinson's in genetically targeted patients
Disease control Recruiting nowThis Phase 2 trial tests an oral drug called NEU-411 in 150 adults aged 40-80 with early Parkinson's disease who have a specific genetic marker (LRRK2-driven). The study is double-blind and placebo-controlled, meaning neither patients nor doctors know who gets the real drug. Rese…
Matched conditions: PARKINSON DISEASE, IDIOPATHIC
Phase: PHASE2 • Sponsor: Neuron23 Inc. • Aim: Disease control
Last updated Jul 02, 2026 03:00 UTC
-
AI wearable could spot Parkinson's freezing episodes at home
Knowledge-focused Recruiting nowThis study tests an artificial intelligence algorithm that uses wearable sensors to detect freezing of gait—a sudden inability to walk—in people with Parkinson's disease. Researchers want to see if the AI works accurately in home environments, not just in the lab. About 126 parti…
Matched conditions: PARKINSON DISEASE, IDIOPATHIC
Sponsor: KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Eye movements may reveal Parkinson's progression
Knowledge-focused Recruiting nowThis study follows 30 people with mild-to-moderate Parkinson's disease for up to 7 years. Researchers use a video eye-tracking device to measure eye movements and compare them with standard neurological and cognitive tests. The goal is to see if eye-tracking can serve as a reliab…
Matched conditions: PARKINSON DISEASE, IDIOPATHIC
Phase: NA • Sponsor: Association de Recherche Bibliographique pour les Neurosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC